Peptide therapy: targeted signaling, applied carefully.

Peptides are short chains of amino acids that function as biological signaling molecules. Your body produces and uses thousands of them naturally — they orchestrate immune response, tissue repair, growth, metabolism, and dozens of other processes. Therapeutic peptide protocols use specific peptide sequences (sometimes natural, sometimes modified) to target specific physiologic processes.

The clinical evidence on peptides is genuinely active and growing. Some peptides have strong human evidence and clear clinical applications. Others have animal data but limited human research. Some are FDA-approved for specific indications; others occupy gray regulatory space. We work carefully within this landscape — staying current with both the evidence and the regulatory status of each protocol we offer.

Strong candidates: patients with specific clinical indications where peptide protocols have evidence — post-injury recovery, metabolic dysfunction, immune dysregulation, body composition challenges. Patients building a comprehensive ASA Bio protocol where peptides integrate with foundational work, BHRT, or stem cell therapy.

Less appropriate candidates: patients seeking "peptides for general anti-aging" without specific clinical drivers, patients expecting transformative results from a single peptide protocol, patients with conditions where peptide therapy could complicate care. We screen carefully and tell patients honestly when peptide therapy is not the right tool.